{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:40:40Z","timestamp":1792791640970,"version":"4.5.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Liver cancer is one of the most ordinary reasons for death among cancers. Hepatocellular carcinoma (HCC) is the most common type of liver cancer. In spite of the fact that various remedial methods have been approved particularly the survival effects of the transcatheter arterial chemoembolization (TACE) method have been accomplished widely in the HCC treatment. By applying the TACE method correctly, good survival outcomes can be achieved without harmfully affecting the hepatic functions. Transarterial chemoembolization mixes the effect of avascular necrosis (AVN) with the effect of regional chemotherapy those are under the influence of arterial embolization. By knowing the fact that the metastases of liver cancer and also perfusion indices in hepatocellular carcinoma (HCC) are via hepatic arteries, doctors chose the TACE method for the treatment of liver cancer. On the other hand, in this method, the radiologists can easily convey antitumor remedies via the arteries. Anyway, medium-level HCC is a sensitive stage of the heterogeneous disease that many patients suffer from, so specialists must consider it as a hazardous syndrome. The TACE procedure could be applied just in cases that the liver function of patients is appropriate yet, the patient liver portal vein do not have any problems and the patients do not have ascites disorder. This review is aimed to figure out the evident advantages of TACE especially by a comprehensive view on the medium level HCC. Because of that this treatment method is suggested as a first-line remedy. At last, the future landscape of the initial factors of research in managing HCC disorders have been summarized.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_2347_20","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T13:07:59Z","timestamp":1637327279000},"page":"3553-3560","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":38,"title":["A review of applying transarterial chemoembolization (TACE) method for management of hepatocellular carcinoma"],"prefix":"10.4103","volume":"10","author":[{"given":"Hossein","family":"Ghanaati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahyar","family":"Mohammadifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Mohammadifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20240828","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-6-20240828","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.3390\/ijms21218165","article-title":"Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma","volume":"21","author":"Chang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R3-6-20240828","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.3390\/app10207337","article-title":"Treatment strategy of transarterial chemoembolization for hepatocellular carcinoma","volume":"10","author":"Miyayama","year":"2020","journal-title":"Appl Sci"},{"key":"R4-6-20240828","doi-asserted-by":"crossref","first-page":"e0227711","DOI":"10.1371\/journal.pone.0227711","article-title":"Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization","volume":"15","author":"Lanza","year":"2020","journal-title":"PLoS One"},{"key":"R5-6-20240828","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ajg.2014.11","article-title":"Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States","volume":"109","author":"Altekruse","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R6-6-20240828","doi-asserted-by":"crossref","first-page":"e25792","DOI":"10.5812\/hepatmon.25792","article-title":"Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma","volume":"14","author":"Firouznia","year":"2014","journal-title":"Hepat Mon"},{"key":"R7-6-20240828","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jvir.2013.01.003","article-title":"Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma:An Asian cooperative study between Japan and Korea","volume":"24","author":"Ikeda","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"R8-6-20240828","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/hepr.13561","article-title":"Comparison of embolic effect between water-in-oil emulsion and microspheres in transarterial embolization for rat hepatocellular carcinoma model","volume":"50","author":"Minamiguchi","year":"2020","journal-title":"Hepatol Res"},{"key":"R9-6-20240828","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/hepr.13411","article-title":"Clinical practice guidelines for hepatocellular carcinoma:The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update","volume":"49","author":"Kokudo","year":"2019","journal-title":"Hepatol Res"},{"key":"R10-6-20240828","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/hepr.13550","article-title":"Transarterial- chemoembolization remains an effective therapy for intermediate-stage hepatocellular carcinoma with preserved liver function","volume":"50","author":"Saito","year":"2020","journal-title":"Hepatol Res"},{"key":"R11-6-20240828","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma:Meta-analysis of randomized controlled trials","volume":"224","author":"Camma","year":"2002","journal-title":"Radiology"},{"key":"R12-6-20240828","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.170.3.2536946","article-title":"Transcatheter oily chemoembolization of hepatocellular carcinoma","volume":"170","author":"Nakamura","year":"1989","journal-title":"Radiology"},{"key":"R13-6-20240828","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/028418519003100405","article-title":"Treatment of hepatocellular carcinoma by segmental hepatic artery injection of adriamycin-in-oil emulsion with overflow to segmental portal veins","volume":"31","author":"Nakamura","year":"1990","journal-title":"Acta Radiol"},{"key":"R14-6-20240828","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3892\/ol.2011.469","article-title":"Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma","volume":"3","author":"Ueda","year":"2012","journal-title":"Oncol Lett"},{"key":"R15-6-20240828","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3892\/mco.2016.998","article-title":"Improved survival with double platinum therapy transcatheter arterial infusion using cisplatin and transcatheter arterial chemoembolization using miriplatin for BCLC-B hepatocellular carcinoma","volume":"5","author":"Ishikawa","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"R16-6-20240828","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrclinonc.2014.122","article-title":"Treatment of intermediate-stage hepatocellular carcinoma","volume":"11","author":"Forner","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"R17-6-20240828","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1097\/MD.0000000000000396","article-title":"Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion","volume":"94","author":"Zhong","year":"2015","journal-title":"Medicine"},{"key":"R18-6-20240828","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.3748\/wjg.v21.i12.3462","article-title":"Management of hepatocellular carcinoma with portal vein thrombosis","volume":"21","author":"Quirk","year":"2015","journal-title":"World J Gastroenterol WJG"},{"key":"R19-6-20240828","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/j.1440-1746.2011.06780.x","article-title":"Portal venous invasion:The single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma","volume":"26","author":"Choi","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R20-6-20240828","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000449335","article-title":"Regorafenib as second-line systemic therapy may change the treatment strategy and management paradigm for hepatocellular carcinoma","volume":"5","author":"Ho","year":"2016","journal-title":"Liver Cancer"},{"key":"R21-6-20240828","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5009\/gnl15022","article-title":"Management of hepatocellular carcinoma:Current status and future directions","volume":"9","author":"Au","year":"2015","journal-title":"Gut lLiver"},{"key":"R22-6-20240828","doi-asserted-by":"crossref","first-page":"844","DOI":"10.4254\/wjh.v6.i12.844","article-title":"Transarterial chemoembolization for hepatocellular carcinoma:A review of techniques","volume":"6","author":"Imai","year":"2014","journal-title":"World J Hepatol"},{"key":"R23-6-20240828","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2214\/AJR.07.2879","article-title":"Chemoembolization of hepatocellular carcinoma:Patient status at presentation and outcome over 15 years at a single center","volume":"190","author":"Brown","year":"2008","journal-title":"Am J Roentgenol"},{"key":"R24-6-20240828","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s002700010070","article-title":"Simulation model based on non-newtonian fluid mechanics applied to the evaluation of the embolic effect of emulsions of iodized oil and anticancer drug","volume":"23","author":"Demachi","year":"2000","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R25-6-20240828","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1872-034X.2008.00466.x","article-title":"Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin","volume":"39","author":"Kawamura","year":"2009","journal-title":"Hepatol Res"},{"key":"R26-6-20240828","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.jvir.2007.07.021","article-title":"Impact of C-arm CT on hepatic arterial interventions for hepatic malignancies","volume":"18","author":"Wallace","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"R27-6-20240828","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jvir.2007.08.003","article-title":"Usefulness of cone-beam volume CT with flat panel detectors in conjunction with catheter angiography for transcatheter arterial embolization","volume":"18","author":"Kakeda","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"R28-6-20240828","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.thorsurg.2014.12.003","article-title":"National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening","volume":"25","author":"Wood","year":"2015","journal-title":"Thorac Surg Clin"},{"key":"R29-6-20240828","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1148\/radiol.11110144","article-title":"Local-regional treatment of hepatocellular carcinoma","volume":"262","author":"Lencioni","year":"2012","journal-title":"Radiology"},{"key":"R30-6-20240828","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00270-011-0287-7","article-title":"Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX):Technical recommendations","volume":"35","author":"Lencioni","year":"2012","journal-title":"Cardiovasc Interv Radiol"},{"key":"R31-6-20240828","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/hep.26256","article-title":"The ART of decision-making:Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma","volume":"57","author":"Sieghart","year":"2013","journal-title":"Hepatol"},{"key":"R32-6-20240828","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000440625","article-title":"Evaluation of ART scores for repeated transarterial chemoembolization in Japanese patients with hepatocellular carcinoma","volume":"89","author":"Arizumi","year":"2015","journal-title":"Oncology"},{"key":"R33-6-20240828","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2014.11.014","article-title":"Retreatment with TACE:The ABCR SCORE, an aid to the decision-making process","volume":"62","author":"Adhoute","year":"2015","journal-title":"J Hepatol"},{"key":"R34-6-20240828","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1007\/s00330-009-1349-y","article-title":"Initial experience of transcatheter arterial chemoembolization during portal vein occlusion for unresectable hepatocellular carcinoma with marked arterioportal shunts","volume":"19","author":"Murata","year":"2009","journal-title":"Eur Radiol"},{"key":"R35-6-20240828","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2214\/ajr.184.2.01840415","article-title":"Temporary occlusion of two hepatic veins for chemoembolization of hepatocellular carcinoma with arteriohepatic vein shunts","volume":"184","author":"Murata","year":"2005","journal-title":"Am J Roentgenol"},{"key":"R36-6-20240828","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000365993","article-title":"Efficacy of sorafenib in intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization","volume":"87","author":"Ogasawara","year":"2014","journal-title":"Oncology"},{"key":"R37-6-20240828","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000367743","article-title":"Effectiveness of sorafenib in patients with transcatheter arterial chemoembolization (TACE) refractory and intermediate-stage hepatocellular carcinoma","volume":"4","author":"Arizumi","year":"2015","journal-title":"Liver Cancer"},{"key":"R38-6-20240828","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4254\/wjh.v8.i17.703","article-title":"Usefulness of staging systems and prognostic scores for hepatocellular carcinoma treatments","volume":"8","author":"Adhoute","year":"2016","journal-title":"World J Hepatol"},{"key":"R39-6-20240828","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1200\/jco.2010.28.15_suppl.4051","article-title":"Efficacy and safety of sorafenib (Sor) in patients (Pts) with advanced hepatocellular carcinoma (HCC):Subgroup analyses of the SHARP trial by baseline (BL) transaminase (ALT\/AST)\/\u03b1-fetoprotein (AFP) and bilirubin (bil) levels","volume":"28","author":"Raoul","year":"2010","journal-title":"J Clin Oncol"},{"key":"R40-6-20240828","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrclinonc.2014.122-c1","article-title":"Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery","volume":"12","author":"Gao","year":"2015","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2347_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:14:24Z","timestamp":1787166864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_2347_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_2347_20","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}